Which has stronger valuation and earnings, SRZNW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is SRZNW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A Alvotech N/A N/A N/A

Which has preferable earnings & valuation, APLMW or SRZNW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Surrozen $11.51M N/A N/A N/A N/A

Is APLMW or SRZNW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Surrozen N/A N/A N/A

Which has better valuation & earnings, SRZNW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is SRZNW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A Aravive N/A N/A N/A

Which has better valuation & earnings, SRZNW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Surrozen $11.51M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is SRZNW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets Surrozen N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has preferable earnings and valuation, BIVIW or SRZNW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Surrozen $11.51M N/A N/A N/A N/A

Is BIVIW or SRZNW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Surrozen N/A N/A N/A

Surrozen (SRZNW) Competitors

$0.0015 0.00 (0.00%)

As of 08/7/2026

Compare

SRZNW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Surrozen stock or one of its competitors? Surrozen's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Surrozen compare to Alvotech?

Surrozen (NASDAQ:SRZNW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

In the previous week, Alvotech had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for Surrozen. Alvotech's average media sentiment score of 0.92 beat Surrozen's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Surrozen	Neutral
Alvotech	Positive

Summary

Alvotech beats Surrozen on 3 of the 3 factors compared between the two stocks.

How does Surrozen compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score.

Company	Overall Sentiment
Apollomics	Neutral
Surrozen	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Surrozen	$11.51M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Surrozen	N/A	N/A	N/A

Summary

Surrozen beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does Surrozen compare to Aravive?

Surrozen (NASDAQ:SRZNW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

In the previous week, Surrozen's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company	Overall Sentiment
Surrozen	Neutral
Aravive	Neutral

Summary

Aravive beats Surrozen on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to bioAffinity Technologies?

Surrozen (NASDAQ:SRZNW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Surrozen	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Surrozen	$11.51M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than Surrozen. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.66 indicating that Surrozen is being referred to more favorably in the media.

Company	Overall Sentiment
Surrozen	Neutral
bioAffinity Technologies	Negative

Summary

Surrozen beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to BioVie?

BioVie (NASDAQ:BIVIW) and Surrozen (NASDAQ:SRZNW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Surrozen	N/A	N/A	N/A

In the previous week, BioVie had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for BioVie and 0 mentions for Surrozen. BioVie's average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score.

Company	Overall Sentiment
BioVie	Neutral
Surrozen	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Surrozen	$11.51M	N/A	N/A	N/A	N/A

Summary

BioVie and Surrozen tied by winning 1 of the 2 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRZNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRZNW vs. The Competition

Export

Metric	Surrozen	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.02B	$7.25B	$12.89B
Dividend Yield	N/A	3.61%	2.53%	8.57%
P/E Ratio	N/A	12.72	273.59	25.45
Price / Sales	N/A	1,361.39	675.80	123.67
Price / Cash	N/A	105.29	76.98	52.10
Price / Book	N/A	16.29	12.89	6.14
Net Income	N/A	-$22.72M	$3.47B	$349.01M
7 Day Performance	N/A	-1.38%	-0.33%	-1.47%
1 Month Performance	N/A	11.06%	6.51%	2.47%
1 Year Performance	N/A	53.71%	25.19%	15.84%

Surrozen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRZNW Surrozen	N/A	$0.00 flat	N/A	-93.1%	$0.00	$11.51M	N/A	80	High Trading Volume
ALVOW Alvotech	N/A	$0.38 flat	N/A	N/A	$0.00	$491.95M	N/A	4
APLMW Apollomics	N/A	$0.01 -2.1%	N/A	+74.7%	$0.00	$8.50M	N/A	59	Positive News Gap Down
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.08 flat	N/A	+519.7%	$0.00	$5.85M	N/A	10	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRZNW) was last updated on 9/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Surrozen (SRZNW) Competitors